JapanHealthcare and life sciences2023 – ongoingSumitomo Pharma
Company-wide generative AI chat tool
Sumitomo Pharma opened a ChatGPT-style chat tool to all employees in May 2023
Problem
The company wanted staff to use generative AI for office work and R&D without risking leaks of company information.
Approach
Sumitomo Pharma launched a browser-based chat tool on OpenAI's engine on 26 May 2023, set up so OpenAI does not reuse the entered data. All employees can use it. Pre-launch tests found it useful for gathering information, drafting internal documents and formatting data. The company planned an enhanced version that would also hold pharmaceutical and drug development information.
Results
No published figures
Takeaway
The company set up a data-protected environment first and tested uses before opening the tool to everyone. It published no usage or savings figures.
Categories
- Industry
- Healthcare and life sciences
- Business function
- Internal work and knowledge managementIT and R&D
- Innovation type
- Process innovation
- AI technology
- Generative AI
- Adoption
- Built in-house
- Evidence
- Company's own claim
Sources
Source summaries
Sumitomo Pharma's release announces company-wide operation of the chat tool from 26 May 2023. It describes the setup that keeps entered data from being reused and the plan for an enhanced version. It gives no quantified results.
Full details are in the original sources.